NCT00004659

Brief Summary

OBJECTIVES: I. Evaluate whether stereotactic radiosurgery provides local control at multiple sites in patients with primary or metastatic brain tumors, controlled systemic disease, and preserved neurologic function. II. Examine survival, clinical outcome, and local tumor imaging response in these patients.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for phase_2

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 1994

Completed
5.3 years until next milestone

First Submitted

Initial submission to the registry

February 24, 2000

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 25, 2000

Completed
Last Updated

June 24, 2005

Status Verified

March 1, 1999

First QC Date

February 24, 2000

Last Update Submit

June 23, 2005

Conditions

Keywords

adult brain tumorbrain tumorchildhood brain tumorgenetic conditionnervous tissue tumorsoncologic disordersrare disease

Interventions

irradiationPROCEDURE
radiosurgeryPROCEDURE

Eligibility Criteria

Age0 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
* Multiple newly diagnosed brain tumors * Histologic confirmation of carcinoma at primary or metastatic site * Tumors less than 25 mm mean diameter and more than 5 mm from optic chiasm * No more than 4 tumors on magnetic resonance imaging * Systemic disease controlled * Neurologic function preserved * Radiographic staging within 2 months of randomization required * Performance status: Karnofsky 70%-100%

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

MeSH Terms

Conditions

Brain NeoplasmsGenetic Diseases, InbornRare Diseases

Interventions

RadiationRadiosurgery

Condition Hierarchy (Ancestors)

Central Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNeoplasmsBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Physical PhenomenaRadiotherapyTherapeuticsStereotaxic TechniquesNeurosurgical ProceduresSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Douglas Kondziolka

    University of Pittsburgh

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Purpose
TREATMENT
Sponsor Type
NIH

Study Record Dates

First Submitted

February 24, 2000

First Posted

February 25, 2000

Study Start

November 1, 1994

Last Updated

June 24, 2005

Record last verified: 1999-03